| ISOFOL MEDICAL AB |
| Schweden |
| Gesundheit |
| SE0009581051 / A2DPV6 |
| 5IU (Frankfurt) |
| FRA:5IU, ETR:5IU, 5IU:GR |
| - |
| https://isofolmedical.com.. |
|
Isofol Medical AB is a biotechnology company that develops advanced cancer therapies, focusing primarily on oncology. Isofol Medical AB aims to enhance the efficacy of current standard chemotherapy treatments through its novel drug candidate, arfolit..
>Volltext.. |
| 17.52 Mio. EUR |
| 5.83 Mio. EUR |
| - |
| -5.13 Mio. EUR |
| -5.08 Mio. EUR |
| -0.02 EUR |
| - |
| 3.94 Mio. EUR |
| -4.87 Mio. EUR |
| 6.07 |
| - |
| -31.99% |
| - |
| - |
| - |
| - |
| ISOFOL |
| 04.04.26 |
|